NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against Spark Therapeutics, Inc. (“Spark” or the “Company”) (ONCE) in connection with the proposed sale of Spark to Roche Holdings, Inc. (“Roche”).
If you are a Spark shareholder and would like to discuss your legal rights and options, please visit Spark (ONCE) Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
The lawsuit alleges that Defendants issued a materially misleading proxy statement recommending that Spark shareholders tender their shares to Roche. According to the complaint, the proxy statement contains materially incomplete and misleading information concerning, among other things, the valuation analyses and methodologies prepared by Sparks’ financial advisor in connection with the rendering of its fairness opinion. As a result, Spark shareholders must be provided with this information in order to adequately assess and value the tender offer. The lawsuit seeks to enjoin the tender offer until such information is disclosed.
If you are a Spark shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/spark-therapeutics-inc-once-merger-roche-stock/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
Our attorneys represent investors all over the world who have fallen victim to securities fraud and corporate misconduct. They have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.